Welcome to LookChem.com Sign In|Join Free

CAS

  • or

506-37-6

Post Buying Request

506-37-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • High quality The extracted Nervonic Acid with low price bulk in supply

    Cas No: 506-37-6

  • USD $ 110.0-120.0 / Kilogram

  • 1 Kilogram

  • 5000 Kilogram/Month

  • Kono Chem Co.,Ltd
  • Contact Supplier

506-37-6 Usage

Description

Nervonic acid, also known as shark oil acid, is a monounsaturated omega-9 fatty acid that exists in nerve tissue and fish oil. It was first discovered in shark brain and is a component of cerebroside, the main source of in shark brain and shark oil. It is also found in the sphingolipids of white matter in human brain. It is the only dual-action miracle substance that can repair nerve fibers that unblock damaged nerve pathways in the brain and promote nerve cell regeneration. Nervonic acid has been identified as important in the biosynthesis of nerve cell myelin. It is used in the treatment of disorders involving demyelination, such as adrenoleukodystrophy and multiple sclerosis where there is a decreased level of nervonic acid in sphingolipids.

Occurrence

Nervonic acid is abundant in King Salmon ( Chinook ) with 140 mg/100g, yellow mustard seed 83 mg/100g , flax seed 64 mg/ 100g, Sockeye salmon 40 mg/100g, sesame seed 35mg/100g, and macademia nuts 18 mg/100g.

Uses

Found in sphingolipids of the white matter of the human brain, neuronic acid is the only magical substance with a dual role in brain development, repairing nerve fibers, unblocking damaged neural pathways in the brain, and promoting nerve cell regeneration. Neuroic acid is very important in the biosynthesis of nerve cell myelin, which together with lignoceric acid accounts for 60% of the acylated fatty acids in white matter sphingomyelin. In demyelinating diseases such as adrenoleukodystrophy and multiple sclerosis, the amount of neuronic acid acylated to sphingolipids is highly reduced, and supplements rich in this fatty acid have been used to help treat these demyelinating diseases.

Definition

ChEBI: Nervonic Acid is a monounsaturated fatty acid with a 24-carbon backbone and the sole double bond originating from the 9th carbon from the methyl end, with this bond in the cis- configuration. It is a metabolite found in the aging mouse brain.

Preparation

Nervonic acid was shown to be identical with selachaleic acid isolated from whale oils. It is obvious that nervonic acid is probably the cis form of erucylacetic acid. Erucylacetic acid has been prepared from erucyl alcohol through the bromide and malonic ester synthesis and has been shown to be identical with nervonic acid obtained from hydrolysis of the cerebroside isolated from human brains.Nervonic acid is also produced from oleic acid, that undergoes three consecutive chain elongation steps, catalyzed by elongases.Two carbon units are added in each step, with production of gadoleic acid, erucic acid, and finally, nervonic acid.

General Description

Nervonic acids are the products of desaturation and elongation processes of various fatty acids such as palmitic acid, stearic acid, oleic acid, etc.

Biochem/physiol Actions

Nervonic acid (C24:1), a component of membrane sphingolipids and phosphatidylethanolamines, may be a useful predictor of chronic kidney disease mortality and diabetes. Nervonic acid oils are being studied for pharmaceutical, nutraceutical and industrial applications. Nervonic acid is a major component of Lunaria oil.

Source

Sources of Nervonic acid include oil crop seeds, oil-producing microalgae and other microorganisms. Transgenic technology can also be used to improve the source and production of Nervonic acid.

Check Digit Verification of cas no

The CAS Registry Mumber 506-37-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,0 and 6 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 506-37:
(5*5)+(4*0)+(3*6)+(2*3)+(1*7)=56
56 % 10 = 6
So 506-37-6 is a valid CAS Registry Number.
InChI:InChI=1/C24H46O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h9-10H,2-8,11-23H2,1H3,(H,25,26)/b10-9-

506-37-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name nervonic acid

1.2 Other means of identification

Product number -
Other names selacholeic

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:506-37-6 SDS

506-37-6Synthetic route

1-hydroxy-cis-15-tetracosene
50995-29-4

1-hydroxy-cis-15-tetracosene

Nervonic acid
506-37-6

Nervonic acid

Conditions
ConditionsYield
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; [bis(acetoxy)iodo]benzene In water; acetonitrile at 20℃; for 7h;70%
(Z)-22-bromo-9-docosene
111924-39-1

(Z)-22-bromo-9-docosene

sodium diethylmalonate
996-82-7

sodium diethylmalonate

A

Nervonic acid
506-37-6

Nervonic acid

B

tetracos-15t-enoic acid
115863-91-7

tetracos-15t-enoic acid

Conditions
ConditionsYield
With ethanol Verseifen des Reaktionsprodukts mit siedender alkoh.KOH und Erhitzen der erhaltenen Dicarbonsaeure auf 175-210grad; die Trennung der beiden Stereoisomeren erfolgt durch fraktionierte Krystallysation aus Aethanol oder Aceton;
With i-Amyl alcohol Verseifen des Reaktionsprodukts mit siedender alkoh.KOH und Erhitzen der erhaltenen Dicarbonsaeure auf 175-210grad; die Trennung der beiden Stereoisomeren erfolgt durch fraktionierte Krystallysation aus Aethanol oder Aceton;
docos-13c-enyl-malonic acid

docos-13c-enyl-malonic acid

Nervonic acid
506-37-6

Nervonic acid

Conditions
ConditionsYield
at 175℃;
cis-Octadecenoic acid
112-80-1

cis-Octadecenoic acid

suberic acid monomethyl ester

suberic acid monomethyl ester

Nervonic acid
506-37-6

Nervonic acid

Conditions
ConditionsYield
With methanol; sodium methylate Electrolysis.Hydrolyse des gebildeten Tetracos-15c-ensaeure-methylesters durch Erwaermen mit wss.-methanol.Natronlauge;
erucyl alcohol
629-98-1

erucyl alcohol

Nervonic acid
506-37-6

Nervonic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: toluene; phosphorus (III)-bromide / 0 - 5 °C
2: sodium ethylate; ethanol / beim Erwaermen des Reaktionsprodukts mit wss.-aethanol. Kalilauge
3: 175 °C
View Scheme
Multi-step reaction with 3 steps
1.1: dmap; triethylamine; methanesulfonyl chloride / dichloromethane / 0 - 20 °C
1.2: 60 °C
2.1: magnesium; iodine / 1 h / Reflux
2.2: 4 h / -40 °C / Inert atmosphere
3.1: [bis(acetoxy)iodo]benzene; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical / acetonitrile; water / 7 h / 20 °C
View Scheme
(Z)-22-bromo-9-docosene
111924-39-1

(Z)-22-bromo-9-docosene

Nervonic acid
506-37-6

Nervonic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium ethylate; ethanol / beim Erwaermen des Reaktionsprodukts mit wss.-aethanol. Kalilauge
2: 175 °C
View Scheme
Multi-step reaction with 2 steps
1.1: magnesium; iodine / 1 h / Reflux
1.2: 4 h / -40 °C / Inert atmosphere
2.1: [bis(acetoxy)iodo]benzene; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical / acetonitrile; water / 7 h / 20 °C
View Scheme
methyl cis-13-docosenoate
1120-34-9

methyl cis-13-docosenoate

Nervonic acid
506-37-6

Nervonic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: lithium alanate; diethyl ether
2: toluene; phosphorus (III)-bromide / 0 - 5 °C
3: sodium ethylate; ethanol / beim Erwaermen des Reaktionsprodukts mit wss.-aethanol. Kalilauge
4: 175 °C
View Scheme
nonan-1-al
124-19-6

nonan-1-al

C26H50O2
856055-61-3

C26H50O2

Nervonic acid
506-37-6

Nervonic acid

Conditions
ConditionsYield
Stage #1: C26H50O2 With potassium hydroxide; water In methanol at 60℃; for 0.333333h;
Stage #2: nonan-1-al With hydrogenchloride In tetrahydrofuran; water
cis-13-docosenoic acid
112-86-7

cis-13-docosenoic acid

Nervonic acid
506-37-6

Nervonic acid

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: sulfuric acid / Reflux
2.1: lithium aluminium tetrahydride / tetrahydrofuran / 20 °C / Inert atmosphere
3.1: dmap; triethylamine; methanesulfonyl chloride / dichloromethane / 0 - 20 °C
3.2: 60 °C
4.1: magnesium; iodine / 1 h / Reflux
4.2: 4 h / -40 °C / Inert atmosphere
5.1: [bis(acetoxy)iodo]benzene; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical / acetonitrile; water / 7 h / 20 °C
View Scheme
ethyl (13Z)-13-docosenoate
37910-77-3

ethyl (13Z)-13-docosenoate

Nervonic acid
506-37-6

Nervonic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: lithium aluminium tetrahydride / tetrahydrofuran / 20 °C / Inert atmosphere
2.1: dmap; triethylamine; methanesulfonyl chloride / dichloromethane / 0 - 20 °C
2.2: 60 °C
3.1: magnesium; iodine / 1 h / Reflux
3.2: 4 h / -40 °C / Inert atmosphere
4.1: [bis(acetoxy)iodo]benzene; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical / acetonitrile; water / 7 h / 20 °C
View Scheme
Methyl oleate
112-62-9

Methyl oleate

Nervonic acid
506-37-6

Nervonic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: lithium aluminium tetrahydride
2: dibromotriphenylphosphorane / dichloromethane
3: (1,2-dimethoxyethane)dichloronickel(II); 4,4',4-tri-tert-butyl-2,2':6',2-terpyridine; manganese / N,N-dimethyl-formamide / 4 h / 40 °C
4: sodium hydroxide / ethanol / 1 h / 60 °C / Inert atmosphere
View Scheme
oleyl alcohol
143-28-2

oleyl alcohol

Nervonic acid
506-37-6

Nervonic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dibromotriphenylphosphorane / dichloromethane
2: (1,2-dimethoxyethane)dichloronickel(II); 4,4',4-tri-tert-butyl-2,2':6',2-terpyridine; manganese / N,N-dimethyl-formamide / 4 h / 40 °C
3: sodium hydroxide / ethanol / 1 h / 60 °C / Inert atmosphere
View Scheme
(Z)-1-bromo-9-octadecene
13044-38-7, 62871-05-0, 6110-53-8

(Z)-1-bromo-9-octadecene

Nervonic acid
506-37-6

Nervonic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: (1,2-dimethoxyethane)dichloronickel(II); 4,4',4-tri-tert-butyl-2,2':6',2-terpyridine; manganese / N,N-dimethyl-formamide / 4 h / 40 °C
2: sodium hydroxide / ethanol / 1 h / 60 °C / Inert atmosphere
View Scheme
methyl cis-tetracos-15-enate
2733-88-2

methyl cis-tetracos-15-enate

Nervonic acid
506-37-6

Nervonic acid

Conditions
ConditionsYield
With sodium hydroxide In ethanol at 60℃; for 1h; Inert atmosphere;
Nervonic acid
506-37-6

Nervonic acid

(Z)-tetracos-15-enoyl chloride
145411-43-4

(Z)-tetracos-15-enoyl chloride

Conditions
ConditionsYield
With thionyl chloride for 2h; Reflux; Inert atmosphere;99%
With oxalyl dichloride for 3h;
With phosphorus pentachloride In diethyl ether at 20℃; for 3h;
Nervonic acid
506-37-6

Nervonic acid

N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

(Z)-Tetracos-15-enoic acid methoxy-methyl-amide
460740-61-8

(Z)-Tetracos-15-enoic acid methoxy-methyl-amide

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 25℃; for 1h;94%
Nervonic acid
506-37-6

Nervonic acid

benzylamine
100-46-9

benzylamine

(Z)-N-benzyltetracos-15-enamide

(Z)-N-benzyltetracos-15-enamide

Conditions
ConditionsYield
Stage #1: Nervonic acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 2h;
Stage #2: benzylamine With dmap In dichloromethane at 20℃; for 18h;
94%
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 1.5h;
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

Nervonic acid
506-37-6

Nervonic acid

nervonic acid N-hydroxysuccinimide ester
191354-88-8

nervonic acid N-hydroxysuccinimide ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In ethyl acetate76%
Nervonic acid
506-37-6

Nervonic acid

(2S,3R,4E)-1-(β-D-galactopyranosyloxy)-2-(15(Z)-tetracosenoylamino)-3-hydroxyoctadec-4-ene
17283-91-9

(2S,3R,4E)-1-(β-D-galactopyranosyloxy)-2-(15(Z)-tetracosenoylamino)-3-hydroxyoctadec-4-ene

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 2h; Heating;64%
(2S,3R,4E)-2-azido-3-benzoyloxy-1-[6-O-(tert-butyldiphenylsilyl)-2-O-levulinyl-3-O-(4-methoxybenzyl)-4-O-{[β-(trimethylsilyl)ethoxy]methyl}-β-D-galactopyranosyloxy]-octadec-4-ene

(2S,3R,4E)-2-azido-3-benzoyloxy-1-[6-O-(tert-butyldiphenylsilyl)-2-O-levulinyl-3-O-(4-methoxybenzyl)-4-O-{[β-(trimethylsilyl)ethoxy]methyl}-β-D-galactopyranosyloxy]-octadec-4-ene

Nervonic acid
506-37-6

Nervonic acid

(2S,3R,4E)-3-benzoyloxy-1-[6-O-(tert-butyldiphenylsilyl)-2-O-levulinyl-3-O-(4-methoxybenzyl)-4-O-{[β-(trimethylsilyl)ethoxy]methyl}-β-D-galactopyranosyloxy]-2-((Z)-tetracos-15-enoylamino)-octadec-4-ene
910898-19-0

(2S,3R,4E)-3-benzoyloxy-1-[6-O-(tert-butyldiphenylsilyl)-2-O-levulinyl-3-O-(4-methoxybenzyl)-4-O-{[β-(trimethylsilyl)ethoxy]methyl}-β-D-galactopyranosyloxy]-2-((Z)-tetracos-15-enoylamino)-octadec-4-ene

Conditions
ConditionsYield
With tributylphosphine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; Staudinger reaction;60%
Nervonic acid
506-37-6

Nervonic acid

(2S,3R,4E)-2-amino-1-(6-O-methoxycarbonylmethyl-α-D-galactopyranosyloxy)octadec-4-en-3-ol

(2S,3R,4E)-2-amino-1-(6-O-methoxycarbonylmethyl-α-D-galactopyranosyloxy)octadec-4-en-3-ol

(2S,3R,4E)-1-(6-O-methoxycarbonylmethyl-α-D-galactopyranosyloxy)-2-[15(Z)-tetracosenoylamino]octadec-4-en-3-ol

(2S,3R,4E)-1-(6-O-methoxycarbonylmethyl-α-D-galactopyranosyloxy)-2-[15(Z)-tetracosenoylamino]octadec-4-en-3-ol

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 4h; Heating;57%
Nervonic acid
506-37-6

Nervonic acid

C24H46O3

C24H46O3

Conditions
ConditionsYield
Stage #1: Nervonic acid With n-butyllithium; isopropylamine In tetrahydrofuran at -55℃; for 0.5h;
Stage #2: With N,N,N,N,N,N-hexamethylphosphoric triamide In tetrahydrofuran at 0 - 20℃; for 16h;
Stage #3: With oxygen In tetrahydrofuran at 0℃; for 1h;
56%
Nervonic acid
506-37-6

Nervonic acid

methoxy PEG2000-4-(4-(1-hydroxyethyl)-2-methoxy-5-nitrophenoxy)butanoate

methoxy PEG2000-4-(4-(1-hydroxyethyl)-2-methoxy-5-nitrophenoxy)butanoate

methoxy PEG2000-4-(2-methoxy-5-nitro-4-(1-(tetracos-15-enoyloxy)ethyl)phenoxy)butanoate

methoxy PEG2000-4-(2-methoxy-5-nitro-4-(1-(tetracos-15-enoyloxy)ethyl)phenoxy)butanoate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane50%
Nervonic acid
506-37-6

Nervonic acid

pentadecanedioic acid
1460-18-0

pentadecanedioic acid

Conditions
ConditionsYield
With chloroform; ozone Beim Spalten des Ozonids mit Wasser auf dem Wasserbad und Oxydieren mit Kaliumpermanganat;
Nervonic acid
506-37-6

Nervonic acid

n-tetracosanoic acid
557-59-5

n-tetracosanoic acid

Conditions
ConditionsYield
With ethanol; platinum Hydrogenation;
With diethyl ether; palladium Hydrogenation;
Nervonic acid
506-37-6

Nervonic acid

tetracos-15t-enoic acid
115863-91-7

tetracos-15t-enoic acid

Conditions
ConditionsYield
With nitros gas
With nitros gas; acetone
Nervonic acid
506-37-6

Nervonic acid

(+/-)-threo-15,16-dihydroxy-tetracosanoic acid
13756-62-2

(+/-)-threo-15,16-dihydroxy-tetracosanoic acid

Conditions
ConditionsYield
With formic acid; dihydrogen peroxide beim anschliessenden Erhitzen mit wss. Natronlauge;
Nervonic acid
506-37-6

Nervonic acid

(+/-)-erythro-15,16-dihydroxy-tetracosanoic acid
13756-62-2

(+/-)-erythro-15,16-dihydroxy-tetracosanoic acid

Conditions
ConditionsYield
With potassium hydroxide; potassium permanganate
Nervonic acid
506-37-6

Nervonic acid

nonanoic acid
112-05-0

nonanoic acid

Conditions
ConditionsYield
With chloroform bei der Ozonspaltung;
Nervonic acid
506-37-6

Nervonic acid

15,16-Dibromo-tetracosanoic acid

15,16-Dibromo-tetracosanoic acid

Conditions
ConditionsYield
With bromine In chloroform
Nervonic acid
506-37-6

Nervonic acid

15,16-Diiodo-tetracosanoic acid

15,16-Diiodo-tetracosanoic acid

Conditions
ConditionsYield
With iodine In chloroform
Nervonic acid
506-37-6

Nervonic acid

15-hydroxylpentadecanoic acid
4617-33-8

15-hydroxylpentadecanoic acid

Conditions
ConditionsYield
With sodium hydroxide; potassium borohydride; ozone 1.) EtOH, hexane; Yield given. Multistep reaction;
diethyl ether
60-29-7

diethyl ether

Nervonic acid
506-37-6

Nervonic acid

palladium charcoal

palladium charcoal

n-tetracosanoic acid
557-59-5

n-tetracosanoic acid

Conditions
ConditionsYield
Hydrogenation;
ethanol
64-17-5

ethanol

Nervonic acid
506-37-6

Nervonic acid

platinum black

platinum black

n-tetracosanoic acid
557-59-5

n-tetracosanoic acid

Conditions
ConditionsYield
Hydrogenation;
Nervonic acid
506-37-6

Nervonic acid

nitros gas

nitros gas

tetracos-15t-enoic acid
115863-91-7

tetracos-15t-enoic acid

Nervonic acid
506-37-6

Nervonic acid

chloroform
67-66-3

chloroform

bromine
7726-95-6

bromine

2.15.16-tribromo-tetracosanoic acid (1)

2.15.16-tribromo-tetracosanoic acid (1)

Conditions
ConditionsYield
Kochen des Reaktionsprodukts mit Brom und rotem Phosphor und Verseifen mit Wasser;
Nervonic acid
506-37-6

Nervonic acid

chloroform
67-66-3

chloroform

A

nonan-1-al
124-19-6

nonan-1-al

B

nonanoic acid
112-05-0

nonanoic acid

C

15-oxo-pentadecanoic acid-(1)

15-oxo-pentadecanoic acid-(1)

D

tridecane-dicarboxylic acid-(1.13)

tridecane-dicarboxylic acid-(1.13)

Conditions
ConditionsYield
Ozonisierung;

506-37-6Relevant articles and documents

A Facile and Efficient Method for the Synthesis of Labeled and Unlabeled Very Long Chain Polyunsaturated Fatty Acids

Hamberg, Mats

, p. 489 - 494 (2021/04/19)

Several methods are available for elongation of fatty acid acyl chains. The present paper describes adaptation to the fatty acid field of a previously published protocol for manganese-based Wurtz type coupling of alkyl bromides. 22-Bromo-3(Z),6(Z),9(Z),12(Z),15(Z),18(Z)-docosahexaene, easily prepared from 4(Z),7(Z),10(Z),13(Z),16(Z),19(Z)-docosahexaenoic acid, was coupled to homologous ω-bromoesters by stirring for 4 hours at 40°C in the presence of manganese powder, a nickel catalyst and terpyridine. This afforded in yields of 70–75% a series of ω3-hexaenoates of chain lengths of 32–40 carbons. The corresponding fatty acids of >98% purity were obtained following saponification and final purification. By using methyl [2,2,3,3,4,4-2H6]10-bromodecanoate as coupling partner it was possible to prepare a very long chain fatty acid in isotopically labeled form, i.e., [2,2,3,3,4,4-2H6]14(Z),17(Z),20(Z),23(Z),26(Z),29(Z)-dotriacontahexaenoic acid. Also prepared were the monounsaturated long chain fatty acids 15(Z)-octadecenoic acid and 15(Z)-tetracosenoic acid. Very long chain fatty acids have been isolated from retina and other tissues and are of biological relevance. The methodology described will assist in further analytical and biological studies in this field.

NOVEL PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS

-

Page/Page column 15, (2010/02/11)

The invention relates to phospholipid-like compounds having defined apolar constituents and to the use of such compounds as liposomes, active ingredients, and solubilizers.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 506-37-6